COPD and risk of venous thromboembolism and mortality in a general population

Børvik Trond, Brækkan Sigrid K., Enga Kristin, Schirmer Henrik, Brodin Ellen E., Melbye Hasse, Hansen John-Bjarne

Source: Eur Respir J 2016; 47: 473-481
Journal Issue: February
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Børvik Trond, Brækkan Sigrid K., Enga Kristin, Schirmer Henrik, Brodin Ellen E., Melbye Hasse, Hansen John-Bjarne. COPD and risk of venous thromboembolism and mortality in a general population. Eur Respir J 2016; 47: 473-481

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The incidence of venous thromboembolism recurrence in patients after first episode acute pulmonary embolism and related risk factors
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


Allergic burden and the risk of venous thromboembolism
Source: Eur Respir J 2013; 42: 1157-1158
Year: 2013


Allergic burden and the risk of venous thromboembolism
Source: Eur Respir J 2013; 42: 1158-1159
Year: 2013


Asthma and risk of pulmonary thromboembolism
Source: Eur Respir J 2014; 43: 1534-1535
Year: 2014


The prevalence of hyperhomocysteinemia in venous thromboembolism
Source: Eur Respir J 2006; 28: Suppl. 50, 48s
Year: 2006

Age is a major risk factor of venous thromboembolism (VTE)
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011

Arterial hypertension and the risk of severity and mortality of COVID-19
Source: Eur Respir J, 55 (6) 2001148; 10.1183/13993003.01148-2020
Year: 2020



Risk factors in patients with venous thromboembolism
Source: Eur Respir J 2002; 20: Suppl. 38, 239s
Year: 2002

Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study
Source: Eur Respir J 2014; 43: 801-807
Year: 2014



The COPD frequency in patients with venous thrombosis
Source: Eur Respir J 2005; 26: Suppl. 49, 57s
Year: 2005

MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension.
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020


Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis?
Source: Eur Respir J 2016; 47: 369-373
Year: 2016


Venous thromboembolism associated with reduced lung function, dyspnoea and asthma in the general population
Source: Virtual Congress 2021 – Insights into pulmonary embolism
Year: 2021



Characteristic and risk factors of chronic thromboembolic pulmonary hypertension: experience in a general hospital
Source: Eur Respir J 2007; 30: Suppl. 51, 602s
Year: 2007

Is venous thromboembolism (VTE) a high risk factor in patients with acute exacerbation of CPOD (AECOPD)?
Source: Eur Respir J 2006; 28: Suppl. 50, 178s
Year: 2006

Risk of venous thromboembolism in lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 73s
Year: 2004

Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case?control study from Sweden
Source: Eur Respir J , 49 (2) 1601014; DOI: 10.1183/13993003.01014-2016
Year: 2017



The incidence of chronic thromboembolic pulmonary hypertension (CTEPH): a 25-year population-based study
Source: Eur Respir J 2003; 22: Suppl. 45, 462s
Year: 2003

The acquired and inherited risk factors in venous thromboembolism (VTE)
Source: Eur Respir J 2003; 22: Suppl. 45, 220s
Year: 2003